Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Oxford Cannabinoid Technologies Holdings PLC (OCTP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.37 +0.02    +4.29%
24/04 - Closed. Currency in GBP ( Disclaimer )
  • Volume: 25,074,211
  • Bid/Ask: 0.36 / 0.43
  • Day's Range: 0.33 - 0.39
Type:  Equity
Market:  United Kingdom
ISIN:  GB00BMVMRB86 
SEDOL:  BMVMRB8
Oxford Cannabinoid Technologies Holdings 0.37 +0.02 +4.29%

Oxford Cannabinoid Technologies Holdings Company Profile

 
Read the Oxford Cannabinoid Technologies Holdings PLC company profile to learn more about the business and the management team. View Oxford Cannabinoid Technologies Holdings PLC facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

7

Equity Type

ORD

Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase – I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. In addition, its development pipeline includes cannabinoid derivative products comprising OCT960609, a dual CB1 and CB2 agonist targeting an undisclosed neuropathic pain indications; and immunotherapy agents for the treatment of solid tumours. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.

Contact Information

Address Prama House 267 Banbury Road
Oxford, OX2 7HT
United Kingdom
Phone 44 20 3034 2820
Fax -

Top Executives

Name Age Since Title
Julie Patricia Pomeroy 67 2021 Independent Non-Executive Chair
Indraneil Mahapatra 43 2021 Co-Founder & Non-Executive Director
Clarissa Ann Sowemimo-Coker 42 2018 CEO & Executive Director
Paul William Smalley 50 2022 Finance Director & Executive Director
Charanjit Dhillon 64 2021 Senior Independent Non-Executive Director
Timothy H. Corn 72 2023 Executive Director & Chief Medical Officer
Anthony Dickenson - 2022 Member of Scientific Advisory Board
. Mott - 2024 Independent Non-Executive Director
Robert H. Dworkin - 2022 Member of Scientific Advisory Board
Giorgio Lambru - 2022 Member of Scientific Advisory Board
William Paul Farquhar-Smith - - Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

OCTP Price Commentary

Write your thoughts about Oxford Cannabinoid Technologies Holdings PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Craig Nelson
Craig Nelson Feb 25, 2022 13:42
Saved. See Saved Items.
This comment has already been saved in your Saved Items
russian invasion: 2.00p
Craig Nelson
Craig Nelson Jan 09, 2022 23:26
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2.88p
Craig Nelson
Craig Nelson Dec 24, 2021 9:55
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2.38p VERY Volatile... Only invest what you can afford to Lose....
Craig Nelson
Craig Nelson Dec 15, 2021 10:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2.3p down with everything else
Craig Nelson
Craig Nelson Nov 29, 2021 17:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2.53p up 25%today
Nea Marin
Nea Marin Oct 08, 2021 9:44
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Imperial Brands owns 10.87% of OCTP
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email